Related Experiment Video
Updated: Jan 10, 2026
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Circulating Metabolite Signatures Linking Physical Activity to Inflammatory Bowel Disease Risk and Interactions With
Zixuan He1, Yuhao Sun2, Hanyi Huang3
1Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China; Changhai Clinical Research Unit, Changhai Hospital, Naval Medical University, Shanghai, China; National Key laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, China.
Background & Aims:
Recent studies have demonstrated the protective effect of physical activity on incident inflammatory bowel diseases (IBD), but the underlying mechanism remains unclear, and whether it interacts with genetic susceptibility is still unknown.
Methods:
The study was conducted leveraging large-scale circulating metabolomics data from 2 prospective cohorts, the UK Biobank study and the Whitehall II study. Moderate-to-vigorous physical activity (MVPA) in minutes per day was assessed by questionnaires, and the circulating metabolome was profiled using a high-throughput nuclear magnetic resonance (NMR)-based platform. Incident IBD cases were ascertained using linkage to nationwide primary care data, hospital inpatient records, and death registry data.
Results:
We identified a metabolic signature of 25 metabolites associated with MVPA, reflecting a favorable lipoprotein profile, a shift toward less saturated fatty acid composition, enhanced energy metabolism, and lower systemic inflammation. The signature was validated both internally and externally. During a mean follow-up of 13.3 years, 1182 incident IBD cases were documented among 183,370 UK Biobank participants. In multivariable Cox regressions, both MVPA and its metabolic signature were associated with reduced IBD risk, with a hazard ratio of 0.77 (95% confidence interval, 0.66-0.90) and 0.59 (95% confidence interval, 0.50-0.71) for the highest vs lowest quartile, respectively. The metabolic signature mediated approximately 13.9% of the MVPA-IBD association. Regarding IBD subtypes, MVPA and its metabolic signature were inversely associated with both Crohn's disease (MVPA: P trend < .001; metabolic signature: P trend < .001) and ulcerative colitis (MVPA: P trend = .026; metabolic signature: P trend = .001). We also observed interactions between MVPA, the metabolic signature, and genetic susceptibility to IBD (Pinteraction < .05).
Conclusions:
Our findings indicate a potential role of MVPA in the prevention of IBD, particularly in individuals with a heightened genetic predisposition, and point to possible biological pathways through which physical activity may influence the incidence of IBD.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...